UCB S.A.: all 580 studies

Page 2 of 6. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia GravisCompletedNCT03315130Phase 2Results posted
• A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet SyndromeTerminatedNCT03299842Phase 3Results posted
• A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary GeneralizationCompletedNCT03250377Phase 3Results posted
• A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.CompletedNCT03248531Phase 2Results posted
• A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque PsoriasisCompletedNCT03230292Phase 2Results posted
• Extension Study of RA101495 for Patients With PNH Who Have Completed a Zilucoplan (RA101495) Clinical StudyTerminatedNCT03225287Phase 2Results posted
• A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing SpondylitisCompletedNCT03215277Phase 2Results posted
• Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms ManagementCompletedNCT03103919Phase 4Results posted
• A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With EpilepsyCompletedNCT03083665Phase 3Results posted
• Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH PatientsCompletedNCT03078582Phase 2Results posted
• Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia GravisCompletedNCT03052751Phase 2Results posted
• A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic PsoriasisCompletedNCT03051217Phase 2/3Results posted
• Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to EculizumabCompletedNCT03030183Phase 2Results posted
• A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque PsoriasisCompletedNCT03025542Phase 2Results posted
• A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit SettingCompletedNCT03021018Phase 2Results posted
• A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AUCompletedNCT03020992Phase 4Results posted
• A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque PsoriasisCompletedNCT03010527Phase 2Results posted
• A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory ArthritisCompletedNCT02969525Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing SpondylitisCompletedNCT02963506Phase 2Results posted
• A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet SyndromeCompletedNCT02926898Phase 3Results posted
• Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque PsoriasisCompletedNCT02905006Phase 2Results posted
• An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet SyndromeCompletedNCT02823145Phase 3Results posted
• A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus ErythematosusCompletedNCT02804763Phase 2Results posted
• Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune ThrombocytopeniaCompletedNCT02718716Phase 2Results posted
• Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.CompletedNCT02710890Phase 2/3Results posted
• Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset SeizuresCompletedNCT02687711Results posted
• A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet SyndromeCompletedNCT02682927Phase 3Results posted
• An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyTerminatedNCT02625090Phase 2Results posted
• A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994CompletedNCT02582866Phase 3Results posted
• Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of ASCompletedNCT02552212Phase 3Results posted
• Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to PlaceboCompletedNCT02505542Phase 3Results posted
• A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyCompletedNCT02495844Phase 2Results posted
• Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset SeizuresCompletedNCT02477839Phase 3Results posted
• Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic SeizuresCompletedNCT02408549Phase 3Results posted
• A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic MedicationsCompletedNCT02408523Phase 3Results posted
• Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)CompletedNCT02346240Phase 3Results posted
• An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)CompletedNCT02326298Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)CompletedNCT02326272Phase 3Results posted
• An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044CompletedNCT02319642Phase 3Results posted
• Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain TumorsCompletedNCT02276053Results posted
• A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's DiseaseCompletedNCT02230904Phase 1Results posted
• Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset SeizuresCompletedNCT02192814Phase 3Results posted
• A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure ClustersTerminatedNCT02161185Phase 3Results posted
• A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating MothersCompletedNCT02154425Phase 1Results posted
• A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid ArthritisCompletedNCT02151851Phase 3Results posted
• A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset SeizuresCompletedNCT02124564Phase 3Results posted
• Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic SeizuresTerminatedNCT02088957Phase 2Results posted
• A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the PlacentaCompletedNCT02019602Phase 1Results posted
• Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMUCompletedNCT01999777Phase 3Results posted
• A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.CompletedNCT01969851Phase 2Results posted
• A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset SeizuresCompletedNCT01964560Phase 3Results posted
• Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset SeizuresCompletedNCT01954121Phase 3Results posted
• Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset SeizuresCompletedNCT01921205Phase 3Results posted
• Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset SeizuresCompletedNCT01832038Phase 3Results posted
• Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And ApathyCompletedNCT01782222Phase 4Results posted
• Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated PainCompletedNCT01744496Phase 4Results posted
• Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With EpilepsyCompletedNCT01728077Phase 3Results posted
• A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's DiseaseCompletedNCT01723904Phase 3Results posted
• A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's DiseaseCompletedNCT01711866Phase 4Results posted
• A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset SeizuresCompletedNCT01710657Phase 3Results posted
• Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination TherapyCompletedNCT01673282Results posted
• Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)CompletedNCT01653262Phase 3Results posted
• Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease PatientsCompletedNCT01646268Phase 3Results posted
• Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease PatientsCompletedNCT01646255Phase 3Results posted
• Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s DiseaseCompletedNCT01606670Results posted
• Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)CompletedNCT01569464Phase 3Results posted
• Pediatric Arthritis Study of Certolizumab PegolCompletedNCT01550003Phase 3Results posted
• A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring HemodialysisCompletedNCT01537042Phase 3Results posted
• Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal DysfunctionTerminatedNCT01536015Phase 3Results posted
• The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid ArthritisTerminatedNCT01533714Phase 2Results posted
• Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure ClustersTerminatedNCT01529034Phase 3Results posted
• Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease PatientsCompletedNCT01523301Phase 4Results posted
• A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid ArthritisCompletedNCT01521923Phase 3Results posted
• Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's DiseaseTerminatedNCT01519882Phase 4Results posted
• A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid ArthritisCompletedNCT01519791Phase 3Results posted
• An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal EpilepsyCompletedNCT01506882Phase 3Results posted
• Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to MethotrexateCompletedNCT01500278Phase 4Results posted
• Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial EpilepsyCompletedNCT01498822Phase 4Results posted
• Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs SyndromeCompletedNCT01498120Phase 2Results posted
• Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs SyndromeCompletedNCT01495793Phase 2Results posted
• Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired PatientsCompletedNCT01491113Phase 4Results posted
• eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetamCompletedNCT01484977Phase 3Results posted
• Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and OlderCompletedNCT01465997Phase 3Results posted
• Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs SyndromeCompletedNCT01455012Phase 4Results posted
• Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid ArthritisCompletedNCT01443364Phase 4Results posted
• Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus ErythematosusCompletedNCT01408576Phase 3Results posted
• An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset SeizuresCompletedNCT01407523Phase 2Results posted
• Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic TherapyCompletedNCT01405508Phase 3Results posted
• An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic SeizuresCompletedNCT01398956Phase 3Results posted
• Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure ClustersTerminatedNCT01390220Phase 3Results posted
• Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced AugmentationCompletedNCT01386944Results posted
• Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to LacosamideTerminatedNCT01375374Phase 3Results posted
• Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With EpilepsyCompletedNCT01364597Phase 3Results posted
• Brivaracetam Safety and Efficacy Follow-up Study in Subjects With EpilepsyCompletedNCT01339559Phase 3Results posted
• Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver SupportCompletedNCT01330290Results posted
• Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor SymptomsCompletedNCT01300819Phase 4Results posted
• Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056TerminatedNCT01296711Phase 2Results posted
• A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic SeizuresCompletedNCT01292837Phase 3Results posted
• A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA)TerminatedNCT01292265Phase 3Results posted
• Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) PatientsCompletedNCT01288287Results posted

← UCB S.A. overview and focus areas